CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

/ 3
Filters:
Show search box
2013-01-08 to 2013-01-09
Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3

Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
 The largest biotech center in Eastern Europe in Vilnius already open

The largest biotech center in Eastern Europe in Vilnius already open

The Biotechpharma Research and Development Center was built and fully equipped in just 14 months and the investment claimed 56 mln Lt from which 38 mln Euro was obtained from European Structural Founds. It is claimed to be the most modern biotech center in the Eastern Europe and be competitive in co... Read more
Tags biotechnology , pharma , lithuania
Will Adamed win against cancers? Part III of the interview with Dr Jerzy Pieczykolan about

Will Adamed win against cancers? Part III of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags bioforum , biotechnology , poland , pharma
Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan ab

Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
Cardiovascular diseases treatment in projects of Pharmahungary Group

Cardiovascular diseases treatment in projects of Pharmahungary Group

The Hungarian Pharmahungary Group is a strong company that provides preclinical and clinical R&D services. Their specialization is cardiovascular and metabolic diseases treatment. But, in fact, what did they achive to be proud of?... Read more
Tags pharma , hungary
2012-12-05 to 2012-12-06
Supergenerics - Pharma’s freshmaker!

Supergenerics - Pharma’s freshmaker!

‘Boring’ white pills no longer do the trick from a marketing point of view. Furthermore governments and payers are looking at reducing the prices of the drugs as the way to contain costs. Additionally, margins of drugs are falling. Because of these two reasons there is a strong competition among com... Read more
Tags bioforum , events , pharma
Biotech and Pharma professionals getting together to overcome challenges and develop genuin

Biotech and Pharma professionals getting together to overcome challenges and develop genuine partnerships

In the aftermath of the global recession, the pharmaceutical and biotechnology industry has been facing new challenges. In the transforming environment - from healthcare reforms, the near-extinction of blockbuster drugs, to changing regulations - companies have little choice but to adapt their approa... Read more
Tags biotechnology , pharma
2012-11-28 to 2012-11-30
Prix Galien - first time in Poland!

Prix Galien - first time in Poland!

The first edition of prestigious Prix Galien Poland 2012 contest was closed on the 20th November of 2012. The awards are being given to the most groundbreaking and innovative solutions in the field of medicine and pharma for more than 40 years. Five gold medals were given away during the glamorous ce... Read more
Tags poland , medicine , events , pharma
Russia corners the market of clinical trials

Russia corners the market of clinical trials

Lately, increased activity in clinical trials could be observed in the Russian market. Only in the second quarter of 2012 275 trials were approved, which is a 44% jump from the same period in 2011. According to Vladimir Putin words, Russia aims for being a super power in the sector of biomedicine and... Read more
Tags biotechnology , pharma , russia
Mabion obtains positive FDA-EMA report

Mabion obtains positive FDA-EMA report

Mabion SA — Polish biotechnological company, which develops and introduces the latest generation of drugs based on humanized monoclonal antibodies to the market, has received a document informing about termination of Scientific Advice joint procedure conducted by the European Medicines Agency and t... Read more
Tags biotechnology , poland , pharma , interview
2012-11-13
Patents of those pharmaceutical drugs expire in 2013

Patents of those pharmaceutical drugs expire in 2013

In 2013, many drugs lose their patents claims, which will result in the confusion on the market of drugmakers. According to EvaluatPharma estimations, pharmaceutical companies will not only lose the market exclusivity on their top selling drug, but also suffer from tremendous decrease of their income... Read more
Tags pharma
2012-10-29
The Top CEE biotech licensing opportunities

The Top CEE biotech licensing opportunities

Pharmaceutical companies are looking for sources of new products and technologies in biotechnology industry to extend the existing pipeline. The major objectives of pharmaceutical and biotechnology businesses are to be the first on the market with new therapeutic entities, achieve maximum market pene... Read more
Tags bioforum , biotechnology , pharma
2012-07-31
CEbiotech.com - Media Partner of the PHARM Connect Congress 2013

CEbiotech.com - Media Partner of the PHARM Connect Congress 2013

The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013. The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceutical and biot... Read more
Tags biotechnology , events , pharma , hungary
2012-06-26
Mabion explores Turkish market!

Mabion explores Turkish market!

Mabion co. – Polish biotech company runing research on biosimilar pharmaceuticals– has signed an intent letter on cooperation with Turkish pharma company in terms of introduction of MabionCD20 medicine to the Turkish market. Annual income from sales of MabThera – the reference of MabionCD20 – in Turk... Read more
Tags biotechnology , poland , pharma
2012-06-19
Atorvastatin of Actavis available in next european countries

Atorvastatin of Actavis available in next european countries

Actavis has introduced a drug containing atorvastatin in 8 european markets where patent protection of Lipitor® /Zarator® from Pfizer has just expired. Lipitor®`s generic equivalent produced by Actavis will be from now available in Germany, Denmark, UK, France, Netherlands, France and Italy.... Read more
Tags pharma , europe
UBICHEM Group Adds New Large Scale Manufacturing Site

UBICHEM Group Adds New Large Scale Manufacturing Site

Ubichem Research Ltd announced further growth of its business by adding a new manufacturing site. The new member of the group, UBICHEM Pharma Manufacturing, will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quanti... Read more
Tags biotechnology , pharma , hungary
2012-05-30
EFPIA contributes to IMI €223,7 million programme to tackle antibiotic resistance

EFPIA contributes to IMI €223,7 million programme to tackle antibiotic resistance

EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today by the Innovative Medicines Initiative (IMI) public-private partnership, a €223,7 million programme to tackle antimicrobial resistance and to speed up the development of new antibiotics.... Read more
Tags pharma , europe
 Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Mabion co. – Polish company specialized in medical biotechnology; created to implement research and biosimilar drugs – has recently singed a letter of intent with Sothema Laboratories, company from Marocco, in terms of distribution of the MabionCD20 pharmaceutical in the Maghreb countries (Marocco, A... Read more
Tags biotechnology , poland , pharma
2012-05-14 to 2012-05-15
Directed therapy of Cushing’s disease finally available!

Directed therapy of Cushing’s disease finally available!

We have approached another medical breakthrough: EU has approved the latest Novartis drug – Signifor® – the first pharmaceutical to treat patients with Cushing’s disease. ... Read more
Tags medicine , pharma
Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Successful completion of performance evaluation study; CE Mark for Unyvero™ instrument system and pneumonia application... Read more
Tags medicine , pharma